发明申请
US20050080110A1 Beta 3 adrenergic agonists 失效
β3肾上腺素能激动剂

Beta 3 adrenergic agonists
摘要:
The present invention relates to a β3 adrenergic receptor agonist of formula (I); or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful, e.g., for treating Type 2 diabetes and/or obesity.
公开/授权文献
信息查询
0/0